financetom
Business
financetom
/
Business
/
National Bank on Quebecor's Wireless Opportunity Outside of Quebec
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
National Bank on Quebecor's Wireless Opportunity Outside of Quebec
Jun 28, 2024 10:09 AM

12:48 PM EDT, 06/28/2024 (MT Newswires) -- Some commentators have questioned Quebecor's ability to succeed outside Quebec, given aggressive moves by the Big 3 to smother Freedom pricing over the past 14 months, notes National Bank.

Analyst Adam Shine estimates over 4.6 million wireless subscribers will churn in Ontario, Manitoba, Alberta, and British Columbia this year. While he acknowledges that bundling efforts will reduce pockets of churn, other forces are at play that will elevate it -- temporary/permanent arrivals to Canada, promotional intensity among flanker/fighter brands, and more BYOD subscribers holding onto phones longer. "To those churning, we can add New to Canada and incremental domestic penetration that expand total subscribers by over a million each year."

With the help of a third-party research platform, NBF conducted a survey which asked 1,515 respondents in Vancouver, Calgary, and Toronto questions about their wireless purchasing behaviour. Bottom line -- consumers in these cities are not averse to change. "We see Freedom and Fizz gaining share because it's there for the taking, especially among more cost-conscious consumers," Shine adds.

Price: 28.96, Change: +0.03, Percent Change: +0.10

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Eli Lilly Reports 4 Years of Sustained Remission in Patients With Ulcerative Colitis
Eli Lilly Reports 4 Years of Sustained Remission in Patients With Ulcerative Colitis
Oct 7, 2025
07:21 AM EDT, 10/07/2025 (MT Newswires) -- Eli Lilly ( LLY ) said Tuesday that data from its phase 3 open-label extension study showed that its drug Omvoh, or mirikizumab-mrkz, achieved sustained clinical, endoscopic and steroid-free remission over four years in patients with moderate to severely active ulcerative colitis. After four years of treatment, the company said that 78% of...
Lexeo Says FDA Open to Application Submission for Accelerated Approval of Friedreich Ataxia Cardiomyopathy Treatment
Lexeo Says FDA Open to Application Submission for Accelerated Approval of Friedreich Ataxia Cardiomyopathy Treatment
Oct 7, 2025
07:23 AM EDT, 10/07/2025 (MT Newswires) -- Lexeo Therapeutics ( LXEO ) said Tuesday the US Food and Drug Administration has indicated openness to a biologics license application submission for accelerated approval of its LX2006 candidate for the treatment of Friedreich ataxia cardiomyopathy. The submission will include interim clinical data from ongoing phase I/II studies of LX2006 pooled with new...
Mars set to win unconditional EU nod for $36 billion Kellanova deal, sources say
Mars set to win unconditional EU nod for $36 billion Kellanova deal, sources say
Oct 7, 2025
BRUSSELS, Oct 7 (Reuters) - Candy and snacks giant Mars' $36 billion bid to acquire Pringles maker Kellanova ( K ) is set to clear a major hurdle by winning unconditional European Union antitrust approval, three people with direct knowledge of the matter said. The deal, among the biggest in the sector, would bring under one roof brands ranging from...
Canadian retailer Kits Eyecare misses Q3 sales estimates
Canadian retailer Kits Eyecare misses Q3 sales estimates
Oct 7, 2025
Overview * Kits Eyecare ( KTYCF ) Q3 revenue up 25.1% yr/yr to C$52.4 mln, missing estimates * Adjusted EBITDA for Q3 increased to approximately 5.2% of revenue * New customers grew 27.6% yr/yr to about 99,000 Outlook * Company did not provide specific guidance for future quarters or year Result Drivers * CUSTOMER GROWTH - New customers increased by...
Copyright 2023-2026 - www.financetom.com All Rights Reserved